Literature DB >> 24784838

Prognostic factors for kidney allograft survival in the Eurotransplant Senior Program.

Ralf Bahde1, Thorsten Vowinkel1, Julia Unser1, Christoph Anthoni1, Jens Peter Hölzen1, Barbara Suwelack2, Norbert Senninger1, Heiner H Wolters1.   

Abstract

BACKGROUND: The shortage of organ donors has led to the introduction of the Eurotransplant Senior Program (ESP) to optimize the allocation of kidneys from elderly donors by age-matching. In the face of a rapidly aging population, identification of prognostic factors for kidney allograft survival within the ESP population will be of enormous significance.
MATERIAL AND METHODS: Donor and recipient data from 89 patients transplanted under the ESP protocol between 1999 and 2007 were retrospectively analyzed. Data were correlated with initial graft function, graft survival, acute rejection episodes, serum creatinine levels, glomerular filtration rates, and patient survival using univariate and multivariate analysis. Maximum follow-up was 5 years.
RESULTS: Cold ischemia time (CIT) >16 hours, body mass index (BMI) ≥25 kg/m(2), and kidney re-transplantation were significant risk factors for delayed graft function (DGF). Odds ratio for primary non-function was significantly increased with prolonged CIT, BMI ≥25 kg/m(2), and duration of renal replacement therapy >69 months. CIT >15 h, DGF, and kidney re-transplantation were associated with poor graft survival (P<0.05).
CONCLUSIONS: Risk reduction (e.g., aiming at CIT <15 h) and close surveillance of patients at risk appear to be crucial for allograft survival in the ESP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24784838     DOI: 10.12659/AOT.890125

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  10 in total

Review 1.  Aging and the immune response to organ transplantation.

Authors:  Monica M Colvin; Candice A Smith; Stefan G Tullius; Daniel R Goldstein
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

2.  Influence of the recipient body mass index on the outcomes after kidney transplantation.

Authors:  Juliane Liese; Nils Bottner; Stefan Büttner; Alexander Reinisch; Guido Woeste; Markus Wortmann; Ingeborg A Hauser; Wolf Otto Bechstein; Frank Ulrich
Journal:  Langenbecks Arch Surg       Date:  2017-05-10       Impact factor: 3.445

3.  Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation.

Authors:  Gerold Thölking; Raphael Koch; Hermann Pavenstädt; Katharina Schuette-Nuetgen; Veit Busch; Heiner Wolters; Reinhard Kelsch; Stefan Reuter; Barbara Suwelack
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

4.  Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.

Authors:  Qipeng Sun; Liangqing Hong; Zhengyu Huang; Ning Na; Xuefeng Hua; Yanwen Peng; Ming Zhao; Ronghua Cao; Qiquan Sun
Journal:  Trials       Date:  2017-11-16       Impact factor: 2.279

5.  Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts.

Authors:  Matteo Ravaioli; Maurizio Baldassare; Francesco Vasuri; Gianandrea Pasquinelli; Maristella Laggetta; Sabrina Valente; Vanessa De Pace; Flavia Neri; Antonio Siniscalchi; Chiara Zanfi; Valentina R Bertuzzo; Paolo Caraceni; Davide Trerè; Pasquale Longobardi; Antonio D Pinna
Journal:  Ann Transplant       Date:  2018-01-12       Impact factor: 1.530

6.  Association of Kidney Donor Risk Index with the Outcome after Kidney Transplantation in the Eurotransplant Senior Program.

Authors:  Beate Schamberger; Dario Lohmann; Daniel Sollinger; Raimund Stein; Jens Lutz
Journal:  Ann Transplant       Date:  2018-11-06       Impact factor: 1.530

7.  Outcomes of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program with A Focus on Recipients ≥75 Years.

Authors:  Ilias Zompolas; Robert Peters; Lutz Liefeldt; Lukas J Lehner; Klemens Budde; Bernhard Ralla; Irena Goranova; Andreas Maxeiner; Markus H Lerchbaumer; Stephan R Marticorena Garcia; Martin Kanne; Thorsten Schlomm; Matthias R G Schulz; Frank Friedersdorff
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

8.  The Kidney Donor Profile Index (KDPI) Correlates With Histopathologic Findings in Post-reperfusion Baseline Biopsies and Predicts Kidney Transplant Outcome.

Authors:  Quirin Bachmann; Flora Haberfellner; Maike Büttner-Herold; Carlos Torrez; Bernhard Haller; Volker Assfalg; Lutz Renders; Kerstin Amann; Uwe Heemann; Christoph Schmaderer; Stephan Kemmner
Journal:  Front Med (Lausanne)       Date:  2022-04-29

9.  Evaluation of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program in Comparison to Standard Allocation.

Authors:  Nelly Delali Eklou; Bernd M Jänigen; Przemyslaw Pisarski; Gerd Walz; Johanna Schneider
Journal:  Ann Transplant       Date:  2022-08-16       Impact factor: 1.479

10.  Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay.

Authors:  Philip Zeuschner; Urban Sester; Michael Stöckle; Matthias Saar; Ilias Zompolas; Nasrin El-Bandar; Lutz Liefeldt; Klemens Budde; Robert Öllinger; Paul Ritschl; Thorsten Schlomm; Janine Mihm; Frank Friedersdorff
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.